Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
We figured out the best health care companies to work for in California using data on salaries, company financial health, and employee diversity. You can also search for the best health care companies to work for in any other state or city.

Zippia score 4.6
Cutera was established in the San Francisco Bay Area in 1998 to develop, manufacture, market and sell laser and light based medical devices. Prior to Cutera, the founding engineers pioneered both CO2 and Nd:YAG lasers-today both well established wavelengths in the science of aesthetic lasers. Cutera's key messaging is directed to physicians specializing in cosmetic procedures with a focus on four categories of aesthetic solutions and their brands. Strengths are defined through safety, clinical excellence, physician/patient education, customer training and a worldwide service organization. Further, our Solutions are available on upgradeable platforms to protect your investment and avoid obsolesence.
Zippia score 4.5
Founded in 2000, XDx, Inc. is a molecular diagnostics company based in Brisbane, CA, USA. XDx applies modern genomics technologies to the development of molecular diagnostic assays that translate a patient's immune status into clinically actionable information. XDx has one marketed product, AlloMap Molecular Expression Testing, and other products under development. The proprietary molecular expression technology used by XDx to develop AlloMap testing for heart transplant patient management may be applicable to the post-transplant management of recipients of other organs. The application of gene expression testing to other diseases that involve the activity of the immune system, such as autoimmune and chronic inflammatory diseases, is also being explored.
Zippia score 4.5
To motivate the executives to create long-term sustainable value for our stockholders by aligning individual incentives with stockholder value creation.
Zippia score 4.5
Aimmune Therapeutics is a company operating in the United States biotechnology industry. Its main focus is in the development of product candidates to combat peanut and other food allergies. The company's therapeutic approach, which is referred to as Characterized Oral Desensitization Immunotherapy, is a system designed to desensitize patients to food allergens using characterized biologic products, defined treatment protocols, and support services.
Zippia score 4.3
Myovant Sciences helps women with uterine fibroids and endometriosis and men with prostate cancer by developing new medicines.
Zippia score 4.2
Maverick Therapeutics is a biotech company focused on improving the lives of patients with solid tumor cancers by developing breakthrough T cell immunotherapies with improved safety and efficacy. Their highly innovative platform, COBRA™, is the most advanced bispecific T cell engaging platform in its class, designed to safely target solid tumors with highly specific and potent activity.
Zippia score 3.9
To be a force for good throughout the world by empowering people to improve lives with rewarding business opportunities, innovative products, and an enriching, uplifting culture.
Zippia score 3.6
Unity Biotechnology designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells; and designs senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected.
Zippia score 4.6
BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises three approved products and multiple clinical and pre-clinical product candidates. Approved products include Naglazyme (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; and Kuvan (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany.
Zippia score 4.4
Sangamo Therapeutics is a clinical-stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients' lives using platform technologies in genome editing, gene therapy, gene regulation and cell therapy. The company's product pipeline includes Hemophilia, Central Nervous System, HIV, Lysosomal Storage Disorders, and Hemoglobinopathies.
Zippia score 3.8
Ultragenyx Pharmaceutical develops therapeutics for rare diseases, sometimes referred to as Orphan products. Ultragenyx is a efficient and effective development strategies are essential for success in the rare disease space, in which information may be incomplete or ambiguous, and few development precedents exist. The management team's experience in selecting and developing products with clear mechanisms of action for untreated rare diseases will help Ultragenyx create life-changing therapeutics by leveraging existing yet undeveloped science for these little-known indications.
| Rank | Company | Zippia score |
|---|---|---|
| 1 | Cutera | |
| 2 | CareDx | |
| 3 | Intermune | |
| 4 | Aimmune Therapeutics | |
| 5 | Myovant Sciences | |
| 6 | Maverick Therapeutics | |
| 7 | Pharmanex | |
| 8 | UNITY Biotechnology |